Understanding Sanfilippo Syndrome (MPS III) involves more than knowing its medical name. This guide offers Australian families, people with disability and support coordinators information about the condition, what everyday support can look like and how the NDIS considers access. We focus on individual abilities and goals, not assumptions about a diagnosis.
Understanding Sanfilippo Syndrome (MPS III)
Sanfilippo syndrome (mucopolysaccharidosis type III or MPS III) is a rare inherited lysosomal storage disorder that chiefly affects the brain and spinal cord. It involves difficulty breaking down heparan sulfate, and its four subtypes can have different rates of progression. Development and communication may initially appear typical or only mildly delayed, with increasing support needs as the condition progresses.
People experience disability in different ways. A well-designed support arrangement starts by asking the individual about what matters to them, what helps them participate in everyday life and where practical barriers arise.
Traits, symptoms and functional impacts
Some possible impacts are outlined below. They are not diagnostic criteria, and any medical concern should be assessed by an appropriate professional.
- Developmental delay or loss of previously learned skills over time
- Speech and communication differences
- Sleep disturbance and difficulties with attention or regulation in some children
- Changes in mobility, coordination or personal care ability
- Potential seizures or swallowing difficulties requiring medical guidance
- Variable progression across types IIIA, IIIB, IIIC and IIID
Living with Sanfilippo Syndrome (MPS III): the everyday experience
Families often need predictable care arrangements, support with communication and changing daily living routines, and help maintaining participation as abilities change. It is important to value connection and comfort alongside independence goals.
Functional needs should be described with concrete examples across communication, social interaction, learning, mobility, self-care and self-management. Consider activities the person manages without assistance, those requiring supervision or prompting, and circumstances requiring equipment or hands-on help. This helps avoid overestimating or underestimating needs.
Practical, respectful support strategies
- Use communication tools and cues that suit the child's or adult's current strengths.
- Review equipment, safe transfers and functional goals with appropriate allied health professionals.
- Make activities meaningful and adaptable to changing abilities.
- Coordinate behaviour, sleep and medical issues with qualified clinicians rather than assuming all concerns require a support worker response.
The participant should remain central to choices about their care. Where specialist medical needs exist, the provider must work within trained staff competencies and follow the person's current instructions from qualified clinicians.
Is Sanfilippo Syndrome (MPS III) recognised under the NDIS?
The published List A specifically includes mucopolysaccharidosis Type III, also called Sanfilippo syndrome. The NDIS treats the condition's listing as relevant to the disability requirements, with all other access requirements still applicable.
NDIS disability access is decided using age and residence rules, evidence of one or more impairments that are or are likely to be permanent, substantial reduction in functional capacity, effects on participation, and likely lifetime need for NDIS supports. In relevant situations, an early intervention pathway is also possible. Medical diagnosis and NDIS disability eligibility are not interchangeable.
Compare the NDIS List A, List B and List D historical appendices with the current NDIS disability requirements. List A identifies conditions likely to meet the disability criteria; List B identifies conditions likely to involve a permanent impairment. These descriptions matter when preparing evidence, and neither list is a general catalogue of everyone who is guaranteed a plan.
Evidence to prepare for an NDIS application
Ask treating professionals for information that describes how the person's impairment affects everyday activities. Evidence may include the following, depending on the condition and individual's circumstances:
- Diagnostic evidence specifying a relevant subtype or severity where the published list includes a restriction.
- Professional observations of ongoing impairment, and appropriate clinical information about treatment options.
- Functional assessments showing practical difficulties with personal care, mobility, communication or organising routines.
- Examples of assistance, equipment or supervision required, including how often it is used.
- Information about goals, participation in study, employment or community life, and whether support needs are likely to persist.
A brief account of a typical day and a more difficult day can make the person's actual needs easier to understand. Where an impairment changes over time, describe progression and fluctuations; no one should be judged only by their best day.
Disability supports that may be relevant
A person's approved plan may, where funding and rules permit, include help with self-care and daily living, community participation, skill development, assistive technology and disability-related allied health services such as occupational therapy, physiotherapy or speech pathology. Support coordination may be appropriate for some participants. Decisions must reflect actual goals and funding; no therapy or equipment is automatic because a diagnosis appears on a historical list.
Clinical treatment, medication, surgery, ordinary hospital care and management of health conditions remain principally health-system responsibilities. Disability-related health supports can be eligible in some circumstances under specific NDIS rules. Complex tasks must have the required clinical plans and staff training.
How Beyond Health Services can help
Our team can talk through suitable daily living support, community access, relevant disability-related allied health or nursing services, and support coordination. We value the person's preferred communication methods, routines, identity and goals. We can discuss support requirements with participants, their nominees, families and support coordinators so that staffing and service arrangements are appropriate to the individual's funded needs.
Before services commence, we discuss the referral process, the individual's care requirements and the supports in their NDIS plan.
Frequently asked questions about Sanfilippo Syndrome (MPS III)
What does the NDIS's historical list say about Sanfilippo Syndrome (MPS III)?
The published List A specifically includes mucopolysaccharidosis Type III, also called Sanfilippo syndrome. The NDIS treats the condition's listing as relevant to the disability requirements, with all other access requirements still applicable.
Does a listed diagnosis guarantee NDIS eligibility?
No. The NDIA must consider the full access requirements, including age and residence, functional impairment and individual supporting evidence. Funding decisions are separate from medical diagnoses.
Is Sanfilippo syndrome the same as MPS III?
Yes. Sanfilippo syndrome is the common name for mucopolysaccharidosis type III.
Do all four subtypes progress at the same rate?
No. Subtypes and individuals vary, so supports should be reviewed against their current functional needs.
What if communication abilities change?
Speech pathology and appropriate communication aids may help a person continue expressing choices and participating in daily activities.
How do we start organising disability support?
Identify the person's goals and day-to-day needs, review the funded supports in their plan, and contact a provider to discuss the right service and referral process.
We are here to listen
Tell us about the person's support goals, communication preferences and daily routines so we can discuss next steps that fit their circumstances.
Contact Beyond Health Services · support@beyondhealthservices.com.au
Information reviewed October 2026. General educational information only; not a substitute for clinical assessment or an NDIA decision. Clinical source: health information and condition overview. NDIS source: NDIS access guidance.



















